Andrew Tsai Score: 35
Analyst at
Jefferies
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+29.4%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
56%
14 W / 11 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
79%
11 W / 3 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
7%
1 W / 13 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 14 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
55%
11 W / 9 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
55%
12 W / 10 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
67%
2 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$380.00
Est. +54%
|
$246.34 | $257.93 |
Pending
|
$255.17
+3.6%
|
| May 04, 2026 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$275.00
Est. +21%
|
$227.92 | $257.93 |
Pending
|
$255.17
+12.0%
|
| Mar 16, 2026 |
Alto Neuroscience Inc.
ANRO
|
BUY |
$35.00
Est. +41%
|
$24.78 | $28.44 |
Pending
|
$21.47
-13.4%
|
| Mar 09, 2026 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$100.00
Est. +59%
|
$62.76 | $63.95 |
Pending
|
$52.10
-17.0%
|
| Mar 09, 2026 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$65.00
Est. +6%
|
$61.56 | $63.95 |
Precision Hit (±3%)
|
$52.10
-15.4%
|
| Mar 06, 2026 |
ATAI Life Sciences N.V.
ATAI
|
BUY |
$10.00
Est. +195%
|
$3.39 | $5.50 |
Pending
|
$3.92
+15.6%
|
| Mar 03, 2026 |
Moderna Inc
MRNA
|
SELL |
$37.00
Est. +26%
|
$49.83 | $43.68 (Low) |
Pending
|
$49.91
-0.2%
|
| Mar 03, 2026 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$30.00
Est. +88%
|
$15.98 | $23.85 |
Pending
|
$15.31
-4.2%
|
| Mar 02, 2026 |
Denali Therapeutics Inc
DNLI
|
BUY |
$40.00
Est. +90%
|
$21.00 | $23.46 |
Pending
|
$21.66
+3.1%
|
| Feb 12, 2026 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$100.00
Est. +31%
|
$76.06 | $84.94 |
Pending
|
$66.80
-12.2%
|
| Dec 17, 2025 |
Vistagen Therapeutics Inc.
VTGN
|
BUY |
$0.90
Est. +5%
|
$0.86 | $0.97 |
Target Met
|
$0.58
-33.0%
|
| Nov 21, 2025 |
MapLight Therapeutics, Inc.
MPLT
|
BUY |
$32.00
Est. +141%
|
$13.29 | $33.28 |
Target Met
|
$27.75
+108.8%
|
| Oct 22, 2025 |
Avadel Pharmaceuticals plc
AVDL
|
BUY |
$20.00
Est. +8%
|
$18.55 | $23.57 |
Target Met
|
$21.64
+16.7%
|
| Oct 16, 2025 |
Praxis Precision Medicines Inc
PRAX
|
BUY |
$300.00
Est. +71%
|
$175.76 | $366.52 |
Target Met
|
$266.58
+51.7%
|
| Sep 25, 2025 |
Biogen Inc
BIIB
|
BUY |
$190.00
Est. +38%
|
$137.67 | $205.97 |
Target Met
|
$200.05
+45.3%
|
| Jul 18, 2025 |
Marcus Corp.
MCS
|
BUY |
$30.00
Est. +65%
|
$18.21 | $22.50 |
Pending
|
$22.44
+23.2%
|
| May 28, 2025 |
Rocket Pharmaceuticals Inc
RCKT
|
BUY |
$2.50
Est. +1%
|
$2.48 | $5.45 |
Target Met
|
$2.75
+10.9%
|
| May 20, 2025 |
ATAI Life Sciences N.V.
ATAI
|
BUY |
$5.00
Est. +144%
|
$2.05 | $6.73 |
Target Met
|
$3.92
+91.2%
|
| Oct 21, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$165.00
Est. +30%
|
$127.08 | $138.69 |
Miss
|
$15.31
-88.0%
|
| Oct 21, 2024 |
GE Vernova Inc.
GEV
|
SELL |
$165.00
Est. +40%
|
$274.85 | $252.38 (Low) |
Miss
|
$940.66
-242.2%
|
| Jul 02, 2024 |
Rapport Therapeutics Inc.
RAPP
|
BUY |
$35.00
Est. +38%
|
$25.44 | $29.74 |
Miss
|
$38.40
+50.9%
|
| May 28, 2024 |
Verona Pharma Plc - ADR
VRNA
|
BUY |
$38.00
Est. +204%
|
$12.50 | $76.89 |
Target Met
|
$106.91
+755.3%
|
| May 07, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$105.00
Est. +50%
|
$70.08 | $131.98 |
Target Met
|
$131.87
+88.2%
|
| Oct 13, 2022 |
Relmada Therapeutics Inc
RLMD
|
BUY |
$8.00
Est. +23%
|
$6.48 | - | - |
$6.65
+2.6%
|
| Jul 22, 2022 |
Vistagen Therapeutics Inc.
VTGN
|
SELL |
$0.20
Est. +95%
|
$4.38 | - | - |
$0.58
+86.8%
|
| Jun 22, 2022 |
Athira Pharma Inc
ATHA
|
BUY |
$3.00
Est. +5%
|
$2.85 | $4.41 |
Target Met
|
$6.75
+136.8%
|
Axsome Therapeutics Inc
AXSM
Jun 11, 2026
Signal & Target
BUY
$380.00
Start Price
$246.34
Best Price (1Y)
$257.93
Current Price
$255.17
Return
+3.6%
Axsome Therapeutics Inc
AXSM
May 04, 2026
Signal & Target
BUY
$275.00
Start Price
$227.92
Best Price (1Y)
$257.93
Current Price
$255.17
Return
+12.0%
Alto Neuroscience Inc.
ANRO
Mar 16, 2026
Signal & Target
BUY
$35.00
Start Price
$24.78
Best Price (1Y)
$28.44
Current Price
$21.47
Return
-13.4%
Xenon Pharmaceuticals Inc
XENE
Mar 09, 2026
Signal & Target
BUY
$100.00
Start Price
$62.76
Best Price (1Y)
$63.95
Current Price
$52.10
Return
-17.0%
Xenon Pharmaceuticals Inc
XENE
Mar 09, 2026
Signal & Target
BUY
$65.00
Start Price
$61.56
Best Price (1Y)
$63.95
Current Price
$52.10
Return
-15.4%
ATAI Life Sciences N.V.
ATAI
Mar 06, 2026
Signal & Target
BUY
$10.00
Start Price
$3.39
Best Price (1Y)
$5.50
Current Price
$3.92
Return
+15.6%
Moderna Inc
MRNA
Mar 03, 2026
Signal & Target
SELL
$37.00
Start Price
$49.83
Best Price (1Y)
$43.68
Current Price
$49.91
Return
-0.2%
Sarepta Therapeutics Inc
SRPT
Mar 03, 2026
Signal & Target
BUY
$30.00
Start Price
$15.98
Best Price (1Y)
$23.85
Current Price
$15.31
Return
-4.2%
Denali Therapeutics Inc
DNLI
Mar 02, 2026
Signal & Target
BUY
$40.00
Start Price
$21.00
Best Price (1Y)
$23.46
Current Price
$21.66
Return
+3.1%
BridgeBio Pharma Inc
BBIO
Feb 12, 2026
Signal & Target
BUY
$100.00
Start Price
$76.06
Best Price (1Y)
$84.94
Current Price
$66.80
Return
-12.2%
Vistagen Therapeutics Inc.
VTGN
Dec 17, 2025
Signal & Target
BUY
$0.90
Start Price
$0.86
Best Price (1Y)
$0.97
Current Price
$0.58
Return
-33.0%
MapLight Therapeutics, Inc.
MPLT
Nov 21, 2025
Signal & Target
BUY
$32.00
Start Price
$13.29
Best Price (1Y)
$33.28
Current Price
$27.75
Return
+108.8%
Avadel Pharmaceuticals plc
AVDL
Oct 22, 2025
Signal & Target
BUY
$20.00
Start Price
$18.55
Best Price (1Y)
$23.57
Current Price
$21.64
Return
+16.7%
Praxis Precision Medicines Inc
PRAX
Oct 16, 2025
Signal & Target
BUY
$300.00
Start Price
$175.76
Best Price (1Y)
$366.52
Current Price
$266.58
Return
+51.7%
Biogen Inc
BIIB
Sep 25, 2025
Signal & Target
BUY
$190.00
Start Price
$137.67
Best Price (1Y)
$205.97
Current Price
$200.05
Return
+45.3%
Marcus Corp.
MCS
Jul 18, 2025
Signal & Target
BUY
$30.00
Start Price
$18.21
Best Price (1Y)
$22.50
Current Price
$22.44
Return
+23.2%
Rocket Pharmaceuticals Inc
RCKT
May 28, 2025
Signal & Target
BUY
$2.50
Start Price
$2.48
Best Price (1Y)
$5.45
Current Price
$2.75
Return
+10.9%
ATAI Life Sciences N.V.
ATAI
May 20, 2025
Signal & Target
BUY
$5.00
Start Price
$2.05
Best Price (1Y)
$6.73
Current Price
$3.92
Return
+91.2%
Sarepta Therapeutics Inc
SRPT
Oct 21, 2024
Signal & Target
BUY
$165.00
Start Price
$127.08
Best Price (1Y)
$138.69
Current Price
$15.31
Return
-88.0%
GE Vernova Inc.
GEV
Oct 21, 2024
Signal & Target
SELL
$165.00
Start Price
$274.85
Best Price (1Y)
$252.38
Current Price
$940.66
Return
-242.2%
Rapport Therapeutics Inc.
RAPP
Jul 02, 2024
Signal & Target
BUY
$35.00
Start Price
$25.44
Best Price (1Y)
$29.74
Current Price
$38.40
Return
+50.9%
Verona Pharma Plc - ADR
VRNA
May 28, 2024
Signal & Target
BUY
$38.00
Start Price
$12.50
Best Price (1Y)
$76.89
Current Price
$106.91
Return
+755.3%
Intra-Cellular Therapies Inc
ITCI
May 07, 2024
Signal & Target
BUY
$105.00
Start Price
$70.08
Best Price (1Y)
$131.98
Current Price
$131.87
Return
+88.2%
Relmada Therapeutics Inc
RLMD
Oct 13, 2022
Signal & Target
BUY
$8.00
Start Price
$6.48
Best Price (1Y)
-
Current Price
$6.65
Return
+2.6%
Vistagen Therapeutics Inc.
VTGN
Jul 22, 2022
Signal & Target
SELL
$0.20
Start Price
$4.38
Best Price (1Y)
-
Current Price
$0.58
Return
+86.8%
Athira Pharma Inc
ATHA
Jun 22, 2022
Signal & Target
BUY
$3.00
Start Price
$2.85
Best Price (1Y)
$4.41
Current Price
$6.75
Return
+136.8%